Skip to main content

Summit Trail Advisors, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1698478 NEW YORK, NY

Position in REGN

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$2,331,054
+$375,136 QoQ
Shares Held
3,017
+19.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Summit Trail Advisors, LLC holds $27,745,492 across 30 Biotechnology names. REGN ranks #4 (8.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 REGN
Regeneron Pharmaceuticals, Inc.
This page
3,017 $2,331,054

All Filings in REGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,331,054 3,017
2025-12-31 $1,955,918 2,534
2025-09-30 $1,724,482 3,067
2025-06-30 $1,192,275 2,271
2025-03-31 $1,049,650 1,655
2024-12-31 $994,412 1,396
2024-09-30 $1,461,223 1,390
2024-06-30 $1,321,144 1,257
2024-03-31 $1,105,901 1,149
2023-12-31 $911,665 1,038
2023-09-30 $906,901 1,102
2023-06-30 $764,526 1,064
2023-03-31 $673,769 820
2022-12-31 $478,347 663
2022-09-30 $441,565 641
2022-06-30 $524,923 888
2022-03-31 $597,847 856